Your Mounjaro price guide · October 2026
Mounjaro Plus and Tirzepatide Plus: What They Really Mean (October 2026)
There is no licensed medicine called Mounjaro Plus or tirzepatide plus in the UK. Mounjaro is tirzepatide, a once-weekly injection licensed for weight management and type 2 diabetes, supplied in six strengths from 2.5mg to 15mg.1 "Plus" usually refers to a brand name, a pharmacy name or an unlicensed blend with added ingredients.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Mounjaro Plus is not a licensed UK product; the licensed medicine is Mounjaro (tirzepatide) in six strengths, 2.5mg to 15mg.
-
"Tirzepatide plus" blends with vitamins, glycine or levocarnitine are not licensed Mounjaro and carry no approved safety or efficacy data.
-
"Plus" is also used in pharmacy and brand names, so check who actually dispenses the medicine and whether it is genuine Mounjaro.
-
Mounjaro must not be combined with other GLP-1 medicines, unlicensed research peptides or compounded copies.
-
A genuine Mounjaro KwikPen costs £169.99 at the 2.5mg starting dose, with no add-on mixture needed.
In this guide
01 · The core answer
What does "Mounjaro plus" actually mean?
It does not describe a licensed product. In the UK, Mounjaro is the brand name for tirzepatide, made by Eli Lilly, and it comes as a pre-filled multi-dose KwikPen in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.1 Nothing in that range is called "plus".
When the word appears next to tirzepatide, it normally means one of three things. It may be part of a pharmacy or clinic name. It may be a marketing label for a weight-loss programme that includes the licensed pen plus coaching or an app. Or it may describe a vial or pen that has been mixed with extra ingredients such as a vitamin, an amino acid or levocarnitine.
The first two are harmless if the medicine itself is genuine and prescribed properly. The third is the one to be careful about, because it is not Mounjaro as licensed.
| What you see | What it usually is | Licensed Mounjaro? |
|---|---|---|
| "Mounjaro Plus" as a product | A marketing label, not a Lilly product | No such product exists in the licensed range |
| "Tirzepatide plus" with vitamins, glycine or levocarnitine | A blended or compounded mixture | No; unlicensed, with no safety data |
| "Plus" in a pharmacy or clinic name | A trading name | Depends on what is dispensed; check the register |
| "GLP-1 plus" programme | A bundle of medicine plus support | Only if the medicine inside is genuine Mounjaro or another licensed product |
02 · Your decision
What should you do if you want tirzepatide?
Ask for the licensed medicine, prescribed after a proper consultation. At EverydayMeds, Mounjaro is supplied only after a free online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity.1 Our pens come through official LillyDirect supply, direct from Eli Lilly's UK distribution.
If you want to see current strengths and costs, the Mounjaro pen page with prices and consultation shows them live. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. Stock is in stock, and prices were checked 10 October 2026.
If you are weighing up the wider picture, our weight loss clinic hub explains the licensed options side by side.
03 · Licensed Mounjaro explained
What licensed Mounjaro is, and what it already does
Mounjaro is a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.1 The active ingredient is tirzepatide. Nothing needs to be added to it for it to work as designed.
Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.
That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide. The point matters here because the "plus" in some marketing implies the standard pen is incomplete. It is not. The licensed product has a defined dose ladder, a tested pen and a patient information leaflet that describes exactly what is inside.13
A blend with extra ingredients has none of those protections. The pen's design, the dosing accuracy and the safety information all belong to the licensed product, not to a mixture someone has prepared.
04 · Add-on blends
Tirzepatide plus vitamins, glycine or levocarnitine
Sellers often present these as a "boosted" version that reduces side effects or improves results. Be wary of anyone who makes that claim.
There are several reasons for caution:
- No licence. A mixture is not the KwikPen that the UK regulator assessed. Its strength, purity and stability have not been tested in the way the licensed pen's have.
- No trial data. The weight-loss results quoted for tirzepatide come from trials of tirzepatide itself. They say nothing about a mixture with another ingredient.
- No regulated supply chain. Mounjaro must not be combined with unlicensed "research" peptides or compounded copies, because these combinations have no safety data and no regulated supply chain.1
- Counterfeit risk. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting suspected problems.7
If something promises faster results outside a licensed pathway, that is the warning sign. A prescriber can help with real concerns such as nausea or low appetite using the licensed pen itself, for example by holding a dose longer within the licence. That is a safer route than adding unproven ingredients.
05 · Individual add-ons
B vitamins, glycine and levocarnitine
Each is a separate substance, and each has its own rules. Vitamins and amino acids are sold as supplements in many shops, and that is a different category from a prescription injection.
Taking a vitamin or an amino acid as a separate supplement is a different question from having it mixed into an injection. Our related guides look at the common pairings in more detail, including tirzepatide and glycine and tirzepatide with vitamin B combinations. If you are curious about coenzyme-style add-ons, see our page on NAD and Mounjaro together.
The honest summary is simple. Mixing an ingredient into the injection removes the licensed pen's protections, and the ingredient has not been shown to add anything. If you feel you may be short of a nutrient, speak to your prescriber or GP about testing and a sensible plan rather than adding it to your medicine.
Dosing of supplements is not standardised. Whatever you take alongside Mounjaro, tell your prescriber so it can be reviewed for suitability.
06 · "Plus" brands and programmes
"Plus" in pharmacy names and GLP-1 programmes
A "plus" in a business name does not change the medicine. Some online pharmacies and clinics use the word in their trading names, and some programmes bundle the pen with coaching, apps or meal plans. That can be useful, but it is the same tirzepatide underneath.
What matters is whether the seller is a registered pharmacy and whether the medicine is genuine. The General Pharmaceutical Council keeps a public register of pharmacies and pharmacy professionals, and you can check any seller against it.12 EverydayMeds is registered with the GPhC under number 9012878.
Look for these signs of a legitimate service: a consultation reviewed by a registered prescriber, a prescription before supply, a pharmacy you can look up and genuine KwikPens in sealed packaging. Be cautious about anything offering to supply without a consultation or prescription.
Our guides on GLP-1 plus products and on review-site claims about a plus-branded product look at specific examples. Read reviews with care: a review tells you about service, not about whether a medicine is licensed or safe.
07 · Combining medicines safely
Combining Mounjaro with other products
Mounjaro must not be combined with other GLP-1 medicines, unlicensed "research" peptides (such as retatrutide, which has no UK licence), or compounded copies.1 This is the clearest rule behind the whole "plus" question. Anything that adds another active drug to tirzepatide falls into this category.
Switching between medicines is a separate matter. There is no licensed direct conversion between semaglutide and tirzepatide. Switching is done under prescriber supervision: typically the previous medicine is stopped, a washout interval observed, and Mounjaro started at a dose your prescriber judges appropriate, often the 2.5mg starting dose. Never run two GLP-1 medicines together.1
If you are unsure whether a supplement or another medicine is compatible, ask your prescriber before starting it. Bring the packaging or the ingredient list.
08 · Licensed alternatives
If you want something "more", the licensed options
If "plus" means you want an alternative or an extra option, the licensed choices are clear. The licensed weight-management options are Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg). Ozempic is semaglutide licensed for type 2 diabetes and is not a UK weight-loss medicine, so a regulated UK pharmacy will not supply it for weight loss.1
In the first large head-to-head trial (SURMOUNT-5), adults on tirzepatide lost on average 20.2% of body weight over 72 weeks versus 13.7% on semaglutide 2.4mg (Wegovy). Both are effective, licensed treatments; which suits you depends on your health profile, tolerance and prescriber advice, not the headline number alone.15 Individual results vary. You can look at the Wegovy pen if you want to compare the two.
There is no tablet form of Mounjaro. Two GLP-1 weight-loss tablets are now licensed in the UK: Wegovy tablets and Foundayo. They are different medicines from Mounjaro, with their own dosing, eligibility checks and trial results, and both are prescription-only.
"Natural GLP-1" supplements such as berberine are not medicines, are not regulated for this use and have no comparable trial evidence. They are low-cost supplements with no clinical oversight, and they are not a stand-in for tirzepatide. Our page on glucomannan and konjac capsules covers another "plus" style product in the same category.
09 · Realistic results
What results to expect without add-ons
Weight loss on Mounjaro is gradual by design, and no add-on speeds it up. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month. Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.1
Everyone starts on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself. After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals up to a maximum of 15mg weekly, depending on how you respond and tolerate it. Many people settle at a maintenance dose of 5mg, 10mg or 15mg; higher is not automatically better.1
Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.13 Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.1
That structure, a licensed dose ladder with prescriber review, is the real "plus" worth paying for: clinical oversight. At EverydayMeds, ongoing monthly reviews and side-effect support are included, and repeat orders re-check suitability.
10 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
11 · NHS and spotting scams
NHS access and how to buy safely
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
Whichever route you choose, a few habits keep you safe:
- Buy only from a registered pharmacy that requires a consultation and prescription.
- Be sceptical of offers that name unusual blends, "boosted" pens or dramatic weight-loss claims.
- Check the pen: genuine KwikPens come in sealed packaging with a patient information leaflet.
- Store pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, after which it should be discarded.1
- Report suspected side effects or suspicious products through the Yellow Card scheme.19
For orders with us, delivery is free next-day tracked in discreet, temperature-controlled packaging, with same-day dispatch when ordered by 3pm. Needles, a sharps bin and injection guidance are included with every order. Our free consultation is reviewed by a GPhC-registered prescriber, and unsuitable orders are refunded automatically.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhat is Mounjaro Plus?
What is tirzepatide plus, and how does it differ from tirzepatide?
Does adding vitamins, glycine or levocarnitine to tirzepatide help weight loss?
How much weight can you lose on Mounjaro in 3 months?
Which is safer, Mounjaro or Wegovy?
What drugs should you not take with Mounjaro?
Is there a Mounjaro tablet or a cheaper alternative?
How long does Mounjaro stay in your system after stopping?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 9 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med 2021;384:989–1002
- GPhC — public register of pharmacies and pharmacy professionals
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


